US · ACH
Accendra Health, Inc.
- Sector
- Healthcare · Medical - Distribution
- Headquarters
- Glen Allen, VA 23060
- Website
- owens-minor.com
Price · as of 2025-12-31
$3.74
Market cap 187.18M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $50.84 | +1,259.36% |
| Intrinsic Value(DCF) | $0.94 | -74.87% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $899.49 | +23,950.56% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $23.71 | $19.28 | $0.00 | $7.70 | $25.81 |
| 2012 | $25.35 | $11.13 | $0.00 | $6.51 | $19.44 |
| 2013 | $29.26 | $18.92 | $0.00 | $6.28 | $17.44 |
| 2014 | $28.56 | $14.60 | $0.00 | $0.00 | $12.78 |
| 2015 | $35.51 | $1,544.74 | $0.00 | $2.18 | $19.27 |
| 2016 | $32.24 | $16.77 | $0.00 | $2.26 | $13.46 |
| 2017 | $16.02 | $6.41 | $0.00 | $0.00 | $4.99 |
| 2018 | $4.42 | $1.77 | $0.00 | $0.00 | $0.00 |
| 2019 | $5.60 | $14.68 | $0.00 | $0.00 | $0.00 |
| 2020 | $36.17 | $37.99 | $0.00 | $7.22 | $0.23 |
| 2021 | $39.51 | $59.60 | $0.00 | $22.62 | $69.64 |
| 2022 | $13.33 | $24.69 | $0.00 | $0.00 | $2.96 |
| 2023 | $25.64 | $38.88 | $0.00 | $0.00 | $0.00 |
| 2024 | $10.00 | $27.92 | $0.00 | $0.00 | $0.00 |
| 2025 | $2.35 | $50.84 | $0.00 | $0.00 | $899.49 |
AI valuation
Our deep-learning model estimates Accendra Health, Inc.'s (ACH) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $50.84
- Current price
- $3.74
- AI upside
- +1,259.36%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.94
-74.87% upside
Graham-Dodd
—
— upside
Graham Formula
$899.49
+23,950.56% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ACH | Accendra Health, Inc. | $3.74 | 187.18M | +1,259% | -75% | — | +23,951% | -1.76 | -0.39 | 0.07 | 8.82 | -0.87 | -0.10 | 43.50% | 5.44% | -39.85% | -197.00% | 7.24% | -2.89% | -4.85 | 1.16 | 0.58 | 0.40 | 8.07 | 20254.00% | -7419.00% | 33912.00% | -162.00% | -0.11 | -14.12% | 0.00% | 0.00% | 82.35% | 14.20 | -7.28 | 0.77 | 0.55 |
| ACRS | Aclaris Therapeutics, Inc… | $2.87 | 310.95M | +859% | -54% | — | +777% | -5.76 | 3.63 | 47.81 | -3.46 | — | 3.63 | 73.28% | -975.91% | -829.58% | -50.20% | 2416.55% | -34.10% | 0.00 | — | 5.28 | 5.28 | 0.31 | -6901.00% | -5819.00% | 13383.00% | -12.62% | -1.64 | 1494.19% | 0.00% | 0.00% | 0.00% | -2.92 | -4.72 | 28.46 | -5.14 |
| ALLO | Allogene Therapeutics, In… | $2.78 | 624.75M | +924% | -60% | — | +3,007% | -1.65 | 1.01 | 19304.10 | -0.92 | — | 1.01 | 100.00% | -1241813.64% | -1170863.64% | -55.13% | -144.12% | -43.24% | 0.21 | -1509.39 | 8.54 | 8.29 | -0.06 | -3684.00% | -7684.00% | -1599.00% | -47.33% | -5.64 | -106.03% | 0.00% | 0.00% | 0.00% | -0.82 | -1.11 | 10135.01 | -3.69 |
| BIOA | BioAge Labs, Inc. | $22.27 | 798.49M | — | — | — | — | -0.69 | 0.15 | — | 4.33 | — | 0.15 | 0.00% | — | — | -94.98% | 95.18% | -37.02% | 0.03 | -33.04 | 12.86 | 12.76 | 5.04 | -2246.00% | — | 3826.00% | -106.31% | -1.85 | 63.16% | 0.00% | 0.00% | 772.94% | 3.80 | 5.72 | — | 0.23 |
| CABA | Cabaletta Bio, Inc. | $3.32 | 319.6M | — | — | — | — | -0.79 | 0.60 | — | 0.51 | -1.89 | 0.60 | 0.00% | — | — | -59.64% | -6352.34% | -52.82% | 0.10 | -167.30 | 6.15 | 6.05 | 1.35 | 4182.00% | — | 6674.00% | -98.71% | -3.26 | -4590.51% | 0.00% | 0.00% | 0.00% | 0.45 | 0.63 | — | -2.29 |
| CGC | Canopy Growth Corporation | $1.12 | 576.26M | +725% | -39% | — | +204% | -0.42 | 0.52 | 0.95 | -0.99 | — | 0.72 | 29.56% | -43.55% | -222.35% | -122.35% | -14.04% | -54.48% | 0.72 | -1.57 | 3.12 | 1.95 | -0.49 | -3709.00% | -947.00% | -3809.00% | -69.30% | -1.76 | -21.21% | 0.00% | 0.00% | 102.99% | -4.03 | -2.67 | 1.76 | -16.18 |
| CVRX | CVRx, Inc. | $8.16 | 214.7M | +209% | -60% | — | — | -4.02 | 5.45 | 3.78 | -3.70 | — | 5.45 | 85.33% | -90.49% | -94.10% | -96.59% | -342.22% | -44.76% | 1.29 | -8.80 | 7.63 | 6.49 | 0.49 | -2302.00% | 1045.00% | 60.00% | -19.01% | -3.02 | -272.03% | 0.00% | 0.00% | 0.00% | -3.70 | -4.65 | 3.35 | -5.99 |
| EDIT | Editas Medicine, Inc. | $2.20 | 214.76M | +883% | +13% | — | +6,172% | -0.60 | 1.05 | 4.38 | 0.40 | -1.40 | 1.05 | 100.00% | -777.22% | -733.72% | -98.10% | 1925.86% | -56.40% | 0.26 | — | 3.75 | 3.71 | 0.41 | 4257.00% | -5864.00% | 6005.00% | -154.71% | -2.72 | 1680.16% | 0.00% | 0.00% | 15.11% | 0.37 | 0.43 | -2.89 | -7.20 |
| HITI | High Tide Inc. | $2.53 | 222.23M | +702% | -58% | — | — | -6.02 | 3.49 | 0.51 | -29.64 | -0.58 | -7.28 | 25.85% | -2.43% | -8.54% | -43.96% | -8.04% | -17.05% | 1.71 | -1.08 | 1.37 | 0.54 | -7.42 | 103761.00% | 1372.00% | -4795.00% | 4.40% | 0.24 | 7.47% | 0.46% | -2.80% | 0.46% | -28.19 | 30.34 | 0.69 | 1.39 |
| OM | Outset Medical, Inc. | $3.49 | 63.91M | +1,299% | -32% | — | — | — | 0.43 | 0.45 | 0.16 | — | 0.43 | 39.13% | -55.84% | -68.34% | 0.00% | -100.69% | 0.00% | 0.82 | -4.78 | 6.67 | 5.24 | -1.11 | -8547.00% | 509.00% | -5980.00% | -86.78% | -1.23 | -71.12% | 0.00% | — | 15.34% | 0.15 | 0.21 | -0.08 | -5.38 |
| SGHT | Sight Sciences, Inc. | $5.16 | 272.82M | +483% | -76% | — | — | -2.30 | 1.35 | 1.48 | -0.83 | — | 1.35 | 85.50% | -63.27% | -64.49% | -49.59% | -403.80% | -33.29% | 0.46 | -10.84 | 9.04 | 8.48 | 1.74 | -965.00% | -147.00% | -5261.00% | -19.22% | -1.44 | -181.68% | 0.00% | 0.00% | 0.00% | -0.76 | -1.69 | 0.48 | -1.67 |
About Accendra Health, Inc.
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025. The company was founded in 1882 and is based in Glen Allen, Virginia.
- CEO
- Edward A. Pesicka
- Employees
- 23.2K
- Beta
- 1.34
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.94 ÷ $3.74) − 1 = -74.87% (DCF, example).